ACR 2022 Tweet by Aurelie Najm

DANBIO registry: 1600+ pts RA, AxSpA, PsA

Infiximab biosimilar to biosimilar switch (CT-P13 -> GP1111)

Maintenance at 1yr:
>80%
> withdrawal in original IFX naive, but higher BL DA

Do second time switchers do better because of past switch experience?

Abs#1112 #ACR22 @RheumNow